Your session is about to expire
← Back to Search
Cisplatin for Breast Cancer
Study Summary
This trial is testing a new combination therapy for subjects with TNBC who have progressed after previous SoC chemotherapy. The safety and efficacy of the therapy will be evaluated in two stages.
- Breast Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 256 Patients • NCT01005680Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is recruitment currently open for this investigation?
"According to clinicaltrials.gov, this particular study is no longer recruiting participants, having initially been posted on March 16th 2018 and last updated on the 28th of March 2022. Nonetheless, there are 5148 other trials actively enrolling patients at this moment in time."
What medical conditions are commonly treated with Cisplatin?
"Cisplatin is a well-regarded therapy for macrocytic anemia and has seen success in treating neoplasm metastasis, recurrent cervical cancer, and leukemias."
How many people are actively participating in this experimentation?
"Unfortunately, no new participants are currently being sought for this clinical trial. It was initially posted on March 16th 2018 and last updated on the 28th of March 2022. However, there are many other studies recruiting individuals with triple negative breast neoplasms (2351) or Cisplatin-related issues (2797)."
What prior experiments have been done utilizing Cisplatin?
"Currently, there are over two thousand studies underway to investigate Cisplatin; of these trials, 727 have advanced to Stage 3. Guangzhou and Guangdong in China host numerous clinical trials for this drug with 117505 other locations around the world conducting research as well."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger